Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10117899
APP PUB NO 20150174169A1
SERIAL NO

14516189

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SANGAMO THERAPEUTICS, INC.; OSPEDALE SAN RAFFAELE SRL; FONDAZIONE TELETHON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Genovese, Pietro Milan, IT 13 356
Gregory, Philip D Richmond, US 75 3031
Holmes, Michael C Richmond, US 87 3590
Lombardo, Angelo Leone Milan, IT 7 16
Naldini, Luigi Milan, IT 49 1043

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 6, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 6, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00